Cabergoline
An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.
Year introduced: 2019 (1985)
PubMed search builder options
Subheadings:
Tree Number(s): D03.132.327.287.131, D03.633.400.439.197
MeSH Unique ID: D000077465
Registry Number: LL60K9J05T
Entry Terms:
- 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
- FCE 21336
- FCE-21336
- Galastop
- Cabaser
- Cabergoline Diphosphate
- 1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate
- Cabaseril
- Dostinex
Pharmacologic Action: